|
Morepen Laboratories Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
4320.07 Cr.
|
P/BV
|
3.47
|
Book Value (Rs.)
|
22.75
|
|
52 Week High/Low (Rs.)
|
78/33
|
FV/ML
|
2/1
|
P/E(X)
|
45.54
|
|
Bookclosure
|
19/09/2026
|
EPS (Rs.)
|
1.73
|
Div Yield (%)
|
0.25
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 119.92 | 155.11 | 135.42 | 55.76 | 126.70 |
| | | | | | |
| Net CashFlow From Operating Activities | 32.64 | 32.06 | 73.37 | -91.17 | -57.76 |
| Net Cash Used In Investing Activities | -123.42 | -321.51 | -83.30 | -46.51 | -31.68 |
| Net Cash Used From Financing Activities | 97.40 | 299.89 | 5.20 | 143.54 | 63.85 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 6.62 | 10.44 | -4.72 | 5.86 | -25.58 |
| Cash And Cash Equivalents Begin of Year | 24.57 | 16.95 | 21.67 | 15.80 | 41.39 |
| Cash And Cash Equivalents End Of Year | 31.19 | 27.38 | 16.95 | 21.67 | 15.80 |
